Thrivent Financial For Lutherans Spectrum Pharmaceuticals Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.63 - $1.59 $84,060 - $212,152	-133,429 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$1.27 - $2.42 $991 - $1,890	781 Added 0.59%	133,429 $169,000
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $1,300 - $2,311	605 Added 0.46%	132,648 $289,000
Q2 2021 Aug 19, 2021	BUY	$2.89 - $4.45 $35,179 - $54,169	12,173 Added 10.16%	132,043 $495,000
Q1 2021 May 17, 2021	SELL	$2.9 - $4.09 $325,446 - $458,992	-112,223 Reduced 48.35%	119,870 $391,000
Q3 2020 Nov 10, 2020	SELL	$2.99 - $4.9 $169,278 - $277,413	-56,615 Reduced 19.61%	232,093 $947,000
Q2 2020 Aug 12, 2020	BUY	$2.11 - $3.38 $2,970 - $4,759	1,408 Added 0.49%	288,708 $976,000
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $361,141 - $680,840	197,345 Added 219.38%	287,300 $670,000
Q4 2019 Feb 13, 2020	BUY	$3.5 - $10.35 $997 - $2,949	285 Added 0.32%	89,955 $327,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $48,542 - $66,978	6,905 Added 8.34%	89,670 $744,000
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $37,823 - $57,865	5,139 Added 6.62%	82,765 $713,000
Q1 2019 May 14, 2019	BUY	$9.08 - $11.84 $54,770 - $71,418	6,032 Added 8.43%	77,626 $830,000
Q4 2018 Feb 15, 2019	BUY	$6.39 - $16.99 $39,796 - $105,813	6,228 Added 9.53%	71,594 $626,000
Q3 2018 Nov 15, 2018	BUY	$16.52 - $24.82 $18,551 - $27,872	1,123 Added 1.75%	65,366 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $74,898 - $113,839	5,234 Added 8.87%	64,243 $1.35 Million
Q1 2018 May 08, 2018	SELL	$16.09 - $23.07 $1,641 - $2,353	-102 Reduced 0.17%	59,009 $949,000
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $168,750 - $261,840	12,631 Added 27.18%	59,111 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $406,700 - $653,973	46,480	46,480 $654,000

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account